Molecularly Targeted Therapies for Pediatric Acute Myeloid Leukemia: Progress to Date

ISSN： 1174-5878

Source： Pediatric Drugs, Vol.10, Iss.2, 2008-01, pp. : 85-92

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

New agents for acute myeloid leukemia: is it time for targeted therapies?

By Ferrara Felicetto

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 2, 2012-02 ,pp. : 179-189

Informa Healthcare

Access to resources Recommend Favorite

Beneficial and Adverse Effects of Molecularly Targeted Therapies for Acute Promyelocytic Leukemia in Central Nervous System

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 8, Iss. 5, 2009-11 ,pp. : 387-392

Bentham Science Publishers

Access to resources Recommend Favorite

Xenograft models of primary acute myeloid leukemia for the development of imaging strategies and evaluation of novel targeted therapies.

Current Pharmaceutical Biotechnology, Vol. 17, Iss. 1, 2016-01 ,pp. : 42-51

Bentham Science Publishers

Access to resources Recommend Favorite

Targeted therapies for the myeloid leukaemias

By Maslak P. Scheinberg D.

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 6, 2000-06 ,pp. : 1197-1205

Informa Healthcare

Access to resources Recommend Favorite

Molecularly targeted therapy in myeloid leukaemias

By Craddock Charles

Clinical Medicine, Vol. 7, Iss. 6, 2007-12 ,pp. : 632-635

Royal College Of Physicians

Access to resources Recommend Favorite